Reaction profile

The FDA adverse-event record for nt - hypertrophic dilated cardiomyopathy

Name: NT - hypertrophic dilated cardiomyopathy - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

18 FDA reports name nt - hypertrophic dilated cardiomyopathy, a lower-volume reaction in the CVM extract (VeDDRA 2302). Plate stamps and neighbourhood peers follow.

#2220 of 2,481
by report volume (all reactions): 18
reports citing this reaction: 77.8%
death-coded share: Cat
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. NT - hypertrophic dilated cardiomyopathy has 18 reports now versus 17 in that prior snapshot: 1 more (5.9%).

Report change: +1
Death-coded reports: +0
Death-coded share: −4.6 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to NT - hypertrophic dilated cardiomyopathy changes

FDA AER · VeDDRA plate

Code 2302 VOL-TRACE

VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-CAT · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 18 reports
DEATH-HOT 77.8%
LOWER-Q #2220/2481
PHOTO-FINISH ALBUMIN/GLOBULIN RATI…
SPECIES-CAT Cat · 11
DRUG-LEAD Fluralaner Spot-O… · 2
DESK-WIDE 11 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: ALBUMIN/GLOBULIN RATIO HI, BLD (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around NT - hypertrophic dilated cardiomyopathy

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around NT - hypertrophic dilated cardiomyopathy

NT - hypertrophic dilated cardiomyopathy: high death-coded share in the FDA AER plate

Signature read: NT - hypertrophic dilated cardiomyopathy's 77.8% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 18 named reports in the openFDA extract. Death-coded share is upper-third: 14 of 18 reports (77.8% of named reports). Nearest volume peer: ALBUMIN/GLOBULIN RATIO HI, BLD (±0 reports). Lead species Cat (11). Lead co-reported drug Fluralaner Spot-On Solution (2).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Cat 11

Dog 6

Chicken 1

Breeds Most Affected

Domestic Shorthair 7

Domestic Longhair 2

Tosa 1

Boxer (German Boxer) 1

Pit Bull 1

Alaskan Malamute 1

Rottweiler 1

Cat (other) 1

Chicken (other) 1

Mountain Dog - Bernese 1

Associated Drugs

Fluralaner Spot-On Solution 2

Cefovecin 2

Fluralaner/Moxidectin Spot-On 2

Spinosad 1

Rabies Vaccine 1

Trilostane 1

Fluralaner Chew Tablets 1

Genta/Momet/Clotrim Ear Oint 1

Acepromazine Maleate 1

Rabies Vaccine, Killed Virus 1

Feline Rhinotracheitis Calici Panleukopenia Vaccine, Killed Virus 1

Insulin Injectable Vial 1

Melarsomine Dihydrochloride Injection 1

Itraconazole 1

Gentamicin Sulfate + Betamethasone Valerate 1

Grapiprant 1

Enrofloxacin 1

Finasteride 1

Nitenpyram 1

Rabies In Hhh Adj Pfizer Kv 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for NT - hypertrophic dilated cardiomyopathy (#2220 of 2,481 by report volume); death-coded 77.8%. PlainBreed reaction plate · death-coded share stamp 77.8% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →